AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimi-M-SR 2/500 Tablet

Prescription Icon
Prescription Required

Marketer

Evitalife Pharma Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimi-M-SR 2/500 Tablet

Metformin/Glimepiride extended-release tablets are antidiabetic medications combining two agents for adult type 2 diabetes management. This dual-action therapy regulates blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your glycemic control. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive treatment plan encompassing diet, exercise, and weight management as advised by your healthcare provider. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremor. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests for complete blood count and liver function, are recommended by your physician.

Primary Ingredients of Glimi-M-SR 2/500 Tablet

No text provided to rephrase.

Uses of Glimi-M-SR 2/500 Tablet

Managing Type 2 Diabetes

Major Benefits of Glimi-M-SR 2/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimi-M-SR 2/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimi-M-SR 2/500 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimi-M-SR 2/500 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimi-M-SR 2/500 Tablets with a meal.

How Glimi-M-SR 2/500 Tablet works:

Glimi-M-SR 2/500 combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimi-M-SR 2/500 tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimi-M-SR 2/500 Tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release glimepiride/metformin (2/500 mg) tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimi-M-SR 2/500 tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. In cases of severe kidney disease, Glimi-M-SR 2/500 tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimi-M-SR 2/500 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Individuals with mild to moderate liver disease should typically begin treatment with a low dose of Glimi-M-SR 2/500 Tablets; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glimi-M-SR 2/500 Tablet :

Should you forget to take a Glimi-M-SR 2/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimi-M-SR 2/500 Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimi-M-SR 2/500 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimi-M-SR 2/500 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimi-M-SR 2/500 Tablet and seek immediate medical attention.
Glimi-M-SR 2/500, a tablet combining glimepiride and metformin, treats type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimi-M-SR 2/500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimi-M-SR 2/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimi-M-SR 2/500 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimi-M-SR 2/500 Tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimi-M-SR 2/500 Tablet
57
MRP 70
18% off